5 completed, 1 terminated. 4 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow rotigotine transdermal patch: new trials by email Literature Review of rotigotine transdermal patch trials Research Report on rotigotine transdermal patch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment rotigotine transdermal patch, placebo - Anxiety Disorders, Parkinson Disease | Phase 4 | Terminated | Johns Hopkins University | 4 | 2016-08-01 | 2020-03-31 |
| Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease Rotigotine transdermal patch, Placebo - Alzheimer Disease | Phase 2 | Completed | I.R.C.C.S. Fondazione Santa Lucia | 94 | 2016-06-01 | 2018-12-17 |
| Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations Rotigotine transdermal patch - Parkinson's Disease | Phase 1 | Completed | UCB Pharma | 56 | 2011-04-01 | 2011-08-30 |
| Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body Rotigotine transdermal patch - Healthy Volunteers | Phase 1 | Completed | UCB Pharma | 50 | 2010-01-01 | 2012-05-22 |
| Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body. Rotigotine transdermal patch - Healthy | Phase 1 | Completed | UCB Pharma | 52 | 2008-10-01 | 2014-10-27 |
| Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects Rotigotine transdermal patch - Healthy | Phase 1 | Completed | UCB BIOSCIENCES GmbH | 50 | 2002-10-01 | 2014-10-20 |
Parkinson Disease (2) · Alzheimer Disease (1) · Anxiety Disorders (1)
UCB Pharma (3) · I.R.C.C.S. Fondazione Santa Lucia (1) · Johns Hopkins University (1) · UCB BIOSCIENCES GmbH (1)
Germany (4) · Austria (1) · Italy (1) · United Kingdom (1) · United States (1)
Alessandro Martorana, MD, PhD (1) · Giacomo Koch, MD, PhD (1) · Gregory Pontone, MD (1)
PMID 24006953, PMID 24859851, PMID 25309431, PMID 32667654
K23AG044441 (1)